![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 Creative Peptides (1)
02 Formil Quimica Ltd (1)
03 Piramal Pharma Solutions (4)
04 USP (4)
01 1346600-85-8 (1)
02 189005-44-5 (1)
03 349122-64-1 (1)
04 400038-68-8 (1)
05 400777-11-9 (1)
06 82626-48-0 (2)
07 99294-93-6 (1)
08 Blank (2)
01 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No; Base Control Drug- ZOLPIDE MBase Control Drug %100 (2)
02 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No; Base Control Drug- ZOLPIDE MBase Control Drug %80.2 (1)
03 Material Origin- Chemical Synthesis; USMCA- No; KORUS- No; Base Control Drug- ZOLPIDEMBase Control Drug %80.2 (1)
04 Specs-EP; Secondary Reference Standard (1)
05 Zolpidem shares some characteristics of a family of sedatives called benzodiazepines. Benzodiazepines cause sedation, muscle relaxation, act as anti-convulsants (anti-seizure medications), and reduce anxiety. Zolpidem has selectivity in that it has little of the muscle relaxant and anti-seizure effects and more of the sedative effect. Therefore, it is used primarily as a medication for sleep. More information please visit the website: http://www.creative-peptides.com/product/zolpidem-item-10-101 (1)
06 Blank (4)
01 Brazil (1)
02 U.S.A (9)